tlooto
Sign up
Medicine

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

V. Verwaal, S. Bruin, H. Boot, G. Slooten, H. Tinteren

2008.6.3ANNALS OF SURGICAL ONCOLOGY

DOI: 10.1245/s10434-008-9966-2

tlooto Summary

It is shown that cytoreduction followed by HIPEC does significantly add survival time to patients affected by peritoneal carcinomatosis of colorectal origin and for a selected group, there is a possibility of long-term survival.

Abstract

Abstract is not available.

Citation format

VERWAAL, V., et al. 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. ANNALS OF SURGICAL ONCOLOGY, 2008, 15: 2426–2432.